Your browser doesn't support javascript.
loading
Resection of hypertrophic papillary muscles and mitral valve replacement in a patient with midventricular hypertrophic obstructive cardiomyopathy - a new approach.
Berg, Julian J; Eckstein, Jan; Deutsch, Marcus-André; Gummert, Jan F; Hata, Masatoshi.
Affiliation
  • Berg JJ; Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine- Westphalia, University Hospital Ruhr-University Bochum, Bad Oeynhausen, Germany.
  • Eckstein J; Institute of Radiology, Nuclear Medicine and Molecular Imaging, Heart and Diabetes Center North Rhine-Westphalia, University Hospital Ruhr-University Bochum, Bad Oeynhausen, Germany.
  • Deutsch MA; Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine- Westphalia, University Hospital Ruhr-University Bochum, Bad Oeynhausen, Germany. mdeutsch@hdz-nrw.de.
  • Gummert JF; Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine- Westphalia, University Hospital Ruhr-University Bochum, Bad Oeynhausen, Germany.
  • Hata M; Department of Cardiovascular surgery, Osaka Police Hospital, Osaka, Japan. mhata@oph.gr.jp.
J Cardiothorac Surg ; 19(1): 105, 2024 Feb 22.
Article de En | MEDLINE | ID: mdl-38388907
ABSTRACT
Midventricular hypertrophic obstructive cardiomyopathy (HOCM) is characterized by hypertrophy of the interventricular septum (IVS) and - in rare cases - of the papillary muscles (PM), which subsequently can cause dynamic left ventricular outflow tract obstruction (LVOTO) and severe heart failure symptoms. We report on a rare case of a 44-year-old patient suffering from midventricular HOCM with hypertrophic anterolateral PM and an additional chorda between the PM and the IVS.We describe a new surgical approach via right anterolateral thoracotomy in 3-dimensional (3D) video-assisted minimal-invasive technique with resection of hypertrophic PMs as well as the entire mitral valve-apparatus and valve replacement avoiding septal myectomy and potentially associated complications. After an uneventful procedure clinical symptoms improved from NYHA III-IV at baseline to NYHA 0-I postoperatively and remained stable over a follow-up period of 24 months. Therefore, the presented technique may be considered as a new and alternative approach in patients with hypertrophic PMs and hypertrophic IVS as subtype of midventricular HOCM.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cardiomyopathie hypertrophique / Obstacle à l'éjection ventriculaire Limites: Adult / Humans Langue: En Journal: J Cardiothorac Surg / J. cardiothorac. surg. (Online) / Journal of cardiothoracic surgery (Online) Année: 2024 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cardiomyopathie hypertrophique / Obstacle à l'éjection ventriculaire Limites: Adult / Humans Langue: En Journal: J Cardiothorac Surg / J. cardiothorac. surg. (Online) / Journal of cardiothoracic surgery (Online) Année: 2024 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni